| in a country | 7 | location |
| in select developed markets | 7 | location |
| each year | 6 | temporal |
| new drug → be → approved | 104 |
| new drug → be approved for → use | 16 |
| new drug → be approved for → marketing | 12 |
| new drug → be approved for → sale | 6 |
| new drug → be approved for → clinical use | 3 |
| negative | neutral | positive |
| 0.141 | 0.600 | 0.259 |
| Raw frequency | 141 |
| Normalized frequency | 0.947 |
| Modifier score | 0.610 |
| Perplexity | 138.807 |